Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vir Biotechnology
Pharma
China deal growth, Daiichi CMO, Astellas-Vir—Fierce Pharma Asia
The value of Chinese licensing deals has surged. Daiichi hired John Tsai as its R&D head. Astellas and Vir partnered on a cancer bispecific. And more.
Angus Liu
Feb 27, 2026 9:50am
The most influential people in biopharma in 2023
May 9, 2023 3:00am
'The Top Line': Moderna vs. Pfizer-BioNTech and this week's news
Feb 17, 2023 6:00am
Vir taps Bayer dealmaker De Backer as its next CEO
Jan 25, 2023 11:20am
NICE advises against Merck's Lagevrio, AZ's Evusheld, 3 others
Nov 16, 2022 10:43am
With $296M deal, GSK expands partnership with Samsung Bio
Oct 21, 2022 8:35am
